ZLZ PeptideNAD+
Ordered NAD+ from ZLZ Peptide? Mail in a sample (US only) and let us test it.
Test my supplyZLZ Peptide shows its strongest purity-focus evidence in Retatrutide and Tirzepatide, with GHK-Cu also mostly passing, but the record is dispersed rather than uniformly clean. TB-500, Tesamorelin, and BPC-157 carry the weaker signals from repeated purity or fill misses; recent results often improve, while uneven or absent batch IDs limit traceability.
Corporate and B2B records trace ZLZ’s storefront to a Hunan chemical-intermediate operator with BMK/PMK precursor listings. The report also maps altered-COA allegations, alias-led sales channels, irreversible payment rails, and lookalike-domain risk.
Unlock original COAs
View and download original lab PDFs for Finnrick tests, including ZLZ Peptide rows.
Cancel anytime
About ZLZ Peptide test results from Finnrick
ZLZ Peptide is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 14 peptides and 299 tests, including ratings, observed price signals, recent test dates, and correction history where available.
Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.
The most visible ZLZ Peptide peptides in this dataset are Retatrutide (107 tests) and CJC-1295 (5 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.
Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 200 recent tests.
Ordered NAD+ from ZLZ Peptide? Mail in a sample (US only) and let us test it.
Test my supply